Sinoway Industrial Co., Ltd.

Dabigatran Intermediates 211914-50-0 Dabigatran Intermediates 211914-50-0

Dabigatran Intermediates 211914-50-0
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic Information of Dabigatran Intermediates 211914-50-0

  • CAS No. of key intermediates: 42288-26-6
  • Other Names: 2-(4-Cyanophenylamino)acetic acid
  • MF: C9H8N2O2
  • EINECS No.: 459-560-3
  • Purity: 99%up by HPLC
  • Model Number: Enterprise Standard
  • Appearance: White to off-white powder, White to off-white powder
  • Water by K.F.: NMT 0.5%
  • Any individual impurity: NMT0.1%
  • Total impurity: NMT 0.5%
  • Assay: 98%-102%

Usage of Dabigatran Intermediates 211914-50-0

  • Dabigatran Intermediate,
  • Dabigatran is a novel synthetic direct thrombin inhibitor that is a prodrug of dabigatran, a non-peptide thrombin inhibitor. After oral absorption by the gastrointestinal tract, it is converted in vivo to dabigatran with direct anticoagulant activity. Dabigatran binds to the fibrin-specific binding site of thrombin, preventing the cleavage of fibrinogen to fibrin, thereby blocking the last steps of the coagulation cascade network and thrombus formation. Dabigatran dissociates from fibrin-thrombin binders and exerts reversible anticoagulant effects.

COA of Dabigatran Intermediates 211914-50-0

Dabigatran Intermediates

MORE_DETAIL Dabigatran Intermediates 211914-50-0

Basic Information of Dabigatran Intermediates 211914-50-0

  • CAS No. of key intermediates: 42288-26-6
  • Other Names: 2-(4-Cyanophenylamino)acetic acid
  • MF: C9H8N2O2
  • EINECS No.: 459-560-3
  • Purity: 99%up by HPLC
  • Model Number: Enterprise Standard
  • Appearance: White to off-white powder, White to off-white powder
  • Water by K.F.: NMT 0.5%
  • Any individual impurity: NMT0.1%
  • Total impurity: NMT 0.5%
  • Assay: 98%-102%

Usage of Dabigatran Intermediates 211914-50-0

  • Dabigatran Intermediate,
  • Dabigatran is a novel synthetic direct thrombin inhibitor that is a prodrug of dabigatran, a non-peptide thrombin inhibitor. After oral absorption by the gastrointestinal tract, it is converted in vivo to dabigatran with direct anticoagulant activity. Dabigatran binds to the fibrin-specific binding site of thrombin, preventing the cleavage of fibrinogen to fibrin, thereby blocking the last steps of the coagulation cascade network and thrombus formation. Dabigatran dissociates from fibrin-thrombin binders and exerts reversible anticoagulant effects.

COA of Dabigatran Intermediates 211914-50-0

Dabigatran Intermediates
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//